Recombinant Viral MIP-I Protein

• Supplier: R&D Systems
• Catalog: 600-VA
• Category: Protein
• Prices: $329.00
• Sizes: 25 µg
• Nature: Recombinant
• Source: E. coli -derived Ala25-Ala95
• Purity: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Bioactivity: Measured by its ability to chemoattract BW5147 mouse T lymphoma cells. The ED 50 for this effect is 2-6 ng/mL. Measured by its ability to chemoattract BaF3 mouse pro‑B cells transfected with human CCR8. The ED 50 for this effect is 4-16 ng/mL.
• Endotoxin: <0.10 EU per 1 μg of the protein by the LAL method.
• SwissProt/Accession: YP_001129366
• Gene: LRP4
• Sequence: Ala25

Product References

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen - Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen

Ruffini PA, Biragyn A, Coscia M, Harvey LK, Cha SC, Bogen B, Kwak LW. J Leukoc Biol. 2004 Jul;76(1):77-85. Epub 2004 Apr 9.

Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. - Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1.

Najarro P, Lee HJ, Fox J, Pease J, Smith GL. J Gen Virol. 2003 Dec;84(Pt 12):3325-36.

Identification of full, partial and inverse CC chemokine receptor 3 agonists - Identification of full, partial and inverse CC chemokine receptor 3 agonists

Wan Y, Jakway JP, Qiu H, Shah H, Garlisi CG, Tian F, Ting P, Hesk D, Egan RW, Billah MM, Umland SP. Eur J Pharmacol. 2002 Dec 5;456(1-3):1-10.